84-yr-old man, first in India to get antibody cocktail against Covid-19 mutant

An 84yearold man from Haryana has become the first person in India to be administered the Covid19 drug cocktail which came into limelight after it was administered to former US President Donald Trump when he tested positive for the virus last year Mohabbat Singh who was under treatment for the last five days at Gurugrams Medanta Hospital was on Tuesday given the drug over a 30 minute intravenous supplyThe cocktail of two fast acting antibodiesCasirivimab and Imdevimab is seen as a cuttingedge treatment that will provide protection to Covid19 patients with mild and moderate symptoms before their condition deteriorates and they require hospitalizationThe first batch of the Roche antibody cocktail drug arrived in the country on Monday according to an official announcement by Roche India and Cipla Limited If these antibodies are injected into a patient infected with the Covid19 virus at an early stage when the virus is trying to multiply then it blocks the virus from entering the cells of the patient from where it derives nutrition to multiply So by blocking the virus they are stopping the multiplication of the virus and finally the virus spikes It is one of the blocking mechanisms that is working against the Covid19 virus Doctor Naresh Trehan Chairman and MD of Medanta hospital told ANIAlso ReadAll you need to know about new 2DG drugDr Tehran further said that the antibodies are also effective against the new variant B16172 and this has been verified in laboratories as well The antibody cocktail therapy is not recommended for patients who are hospitalized due to severe Covid19 or those who require oxygen therapy due to Covid19 or who require an increase in baseline oxygen flow rate due to Covid19 and in patients on chronic oxygen therapy due to underlying nonCovid19 related comorbidityIt has been tested and used extensively in the US and Europe and the experience shows that it works when given timely that means the first seven days of viral replication stage or when the virus multiplies So by blocking it then you are reducing the severity of the disease in everybody but also in those who had a severe infection because of comorbidities along with their age and also a high viral load It has been found effective when given on time the sooner you give it more effective it is Dr Trehan saidThis FDAapproved therapy demonstrated good efficacy in Phase 12 and Phase 3 studies by reducing Covid19 related hospitalization and death by 70 per cent Approved by the Drugs Controller General of India DCGI this single dose infusionbased treatment can be provided on an outpatient or daycare basis and marks a dramatic shift in Covid19 care in IndiaWe are glad to now have access to Monoclonal Antibody Therapy in India This fast and effective treatment for Covid 19 will save patients at the highest risk from falling critically ill getting hospitalized or possibly dying of complications from Covid19 We look forward to serving our patients with this therapy and saving more lives said Dr Naresh Trehan The doctor however said that patients are advised to check with their doctor if monoclonal antibody therapy may be beneficial to them in the treatment of their Covid19 infectionThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever